USFDA nod for dental agent of Novalar gets

Written by Administrator
Wednesday, 14 May 2008
Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company has received approval from United States Food and Drug Administration (USFDA) for marketing approval for OraVerse (phentolamine mesylate). read more...

< Prev		Next >

[ Back ]

QUICK LINKS

11.03.2008 | Retailing

Kmart Pharmacy has launch of the American Fare Dollar Program, which offers pharmacy customers a choice of 10 over-the-counter (OTC) medications from Kmart's proprietary American Fare brand for only… Readmore

09.09.2007 | Outsourcing

The pharmaceutical manufacturers in the United States have attacked the proposed pharma policy of India saying that it would contravene the stated goal of liberalizing the sector, and sought some… Readmore

09.09.2007 | Homeopathy

The Homeopatic manufacturing units must fulfill the conditions stated by the government of India under 67-G Readmore

10.07.2008 | FDA

Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, has received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its SPOT-Light(R) HER2… Readmore

17.07.2008 | Biotechnology

Angel Biotechnology Holdings plc, the biopharmaceutical contract manufacturer, is announced pre-GMP process development programme with Angport Limited. The contract is the first to be signed under the EPhaG relationship… Readmore

18.07.2008 | Nanotechnology

With Bangalore’s position as emerging leader in nanotechnology and as an international business destination growing manifold over the years, Bangalore the nano hub of India is poised to host… Readmore

20.12.2007 | Packaging

Bilcare Research has launched a product to help check the menace of counterfeit drugs. The product has a label with a unique bar code made out of nanotechnology and… Readmore

Advertisement